11-3218305-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001164377.1(MRGPRG):c.509T>A(p.Leu170Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000066 in 151,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164377.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRGPRG | NM_001164377.1 | c.509T>A | p.Leu170Gln | missense_variant | 1/1 | ENST00000332314.3 | NP_001157849.1 | |
MRGPRG-AS1 | NR_027138.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRGPRG | ENST00000332314.3 | c.509T>A | p.Leu170Gln | missense_variant | 1/1 | NM_001164377.1 | ENSP00000330612 | P1 | ||
MRGPRG-AS1 | ENST00000434798.1 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151514Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151514Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73994
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.509T>A (p.L170Q) alteration is located in exon 1 (coding exon 1) of the MRGPRG gene. This alteration results from a T to A substitution at nucleotide position 509, causing the leucine (L) at amino acid position 170 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at